Obesity hypoventilation syndrome can be challenging to manage. Obtaining the appropriate device for each patient is often complicated by insurance requirements and endless red tape. Previous guidelines have indicated that CPAP may be as effective as bi-level PAP; however, this doesn’t apply to all patients. How can we identify patients who may require more advanced treatment modalities while also ensuring that those treatments do not cause undue financial burden for them? Here to help us understand this better is Dr. Babak Mokhlesi.
ADVENT-HF trial
OSA proteomics and metabolomics
Acoustic stimulation for improving sleep
NIV and other considerations for the Philips Respironics PAP device recall
Neurotransmitters, insomnia pharmacotherapy and mental health
Sleep, OSA and sickle cell disease
A Practical Approach to Treating RLS
Sleep and Alzheimer’s disease
Sleep as an Opportunity to Improve Maternal Mortality
Keeping Up with the Changes to the Scoring Manual
Sleep and ADHD in Adolescents
Medications To Manage Central Disorders Of Hypersomnolence
Legal Issues in a Sleep Medicine Practice
Medications to Treat Obstructive Sleep Apnea
Insufficient Sleep, Circadian Disruption and Cardiometabolic Health
DREAM-IT: Insomnia Management in Adolescents
Obesity Management for Sleep Clinicians
Embracing Alternative Practice Models
Navigating the Ethics of Disclosure in RBD
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive